Citi maintains a 'Hold' rating on Eli Lilly (NYSE: LLY), but sees attractive risk/reward.

Citi analyst says, "We expect ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE